Search Results - "Ettinger, LJ"

Allergic Reactions and Anti-Asparaginase Antibodies in Children with High-Risk Acute Lymphoblastic Leukemia: A Children's Oncology Group Report by RH, Ko, Jones, TL, Radvinsky, D, Robison, N, Gaynon, PS, Panosyan, EH, Avramis, IA, Avramis, VI, Rubin, J, Ettinger, LJ, Seibel, NL, Dhall, G

Get full text

A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a children's Cancer Group Study by AVRAMIS, Vassilios I, SENCER, Susan, HILDEN, Joanne M, LANGE, Beverly, MAJLESSIPOUR, Fataneh, MATHEW, Pracad, NEEDLE, Michael, NEGLIA, Joseph, REAMAN, Gregory, HOLCENBERG, John S, PERICLOU, Antonia P, SATHER, Harland, BOSTROM, Bruce C, COHEN, Lewis J, ETTINGER, Alice G, ETTINGER, Lawrence J, FRANKLIN, Janet, GAYNON, Paul S

“…For this study, 118 children with standard-risk acute lymphoblastic leukemia (ALL) were given randomized assignments to receive native or pegylated Escherichia…”
Get full text

Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961 by Panosyan, Eduard H, Seibel, Nita L, Martin-Aragon, Sagrario, Gaynon, Paul S, Avramis, Ioannis A, Sather, Harland, Franklin, Janet, Nachman, James, Ettinger, Lawrence J, La, Mei, Steinherz, Peter, Cohen, Lewis J, Siegel, Stuart E, Avramis, Vassilios I

“…We investigated the anti-asparaginase antibody (Ab) and asparaginase enzymatic activity in the sera of 1,001 patients (CCG-1961) with high-risk acute…”
Get full text

Nephrotic syndrome associated with hypocomplementemia in a 4-year-old boy with hemophilia B by CONSTANTINESCU, A. R, WEISS, L. S, SAIDI, P, EISELE, J, ETTINGER, L. J

“…The case of a 4-year-old boy with hemophilia B with inhibitor who developed nephrotic syndrome is described. The possible association between factor IX therapy…”
Get full text

Intravenous anti-D treatment of immune thrombocytopenic purpura: Experience in 272 patients by SCARADAVOU, A, WOO, B, WOLOSKI, B. M. R, CUNNINGHAM-RUNDLES, S, ETTINGER, L. J, ALEDORT, L. M, BUSSEL, J. B

“…We report the results of intravenous anti-D (WinRho, WinRho SD) therapy in 261 non-splenectomized patients treated at the New York Hospital-Cornell Medical…”
Get full text

Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group by Provisor, A J, Ettinger, L J, Nachman, J B, Krailo, M D, Makley, J T, Yunis, E J, Huvos, A G, Betcher, D L, Baum, E S, Kisker, C T, Miser, J S

“…The specific aims of this study were to improve event-free survival (EFS) in patients with newly diagnosed nonmetastatic osteosarcoma of an extremity using the…”
Get more information

Preradiation Chemotherapy in Primary High-Risk Brainstem Tumors: Phase II Study CCG-9941 of the Children’s Cancer Group by JENNINGS, Mark T, SPOSTO, Richard, ETTINGER, Lawrence J, FITZ, Charles R, LAFOND, Deborah, MANDELBAUM, David E, MASSEY, Vicky, MCGUIRE, Warren, MCNEELY, Lee, MOULTON, Thomas, POLLACK, Lan F, SHEN, Violet, BOYETT, James M, VEZINA, L. Gilbert, HOLMES, Emi, BERGER, Mitchell S, BRUGGERS, Carol S, BRUNER, Janet M, CHAN, Ka-Wah, DUSENBERY, Kathryn E

“…This Children's Cancer Group group-wide phase II trial evaluated the efficacy and toxicity of two chemotherapy arms administered before hyperfractionated…”
Get full text

A phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma : A report of the children's cancer group by FROST, J. D, HANK, J. A, KRAILO, M. D, MATTHAY, K. K, REISFELD, R. A, SONDEL, P. M, REAMAN, G. H, FRIERDICH, S, SEEGER, R. C, GAN, J, ANDERSON, P. M, ETTINGER, L. J, CAIRO, M. S, BLAZAR, B. R

“…The murine monoclonal antibody (MoAb) 14.G2a recognizes GD2, a disialoganglioside expressed in tumors of neuroectodermal origin, and facilitates antibody…”
Get full text

Nephrotic syndrome as a complication of immune tolerance in hemophilia B by Ewenstein, B M, Takemoto, C, Warrier, I, Lusher, J, Saidi, P, Eisele, J, Ettinger, L J, DiMichele, D

Get full text

An open-label, multicenter study of polyethylene glycol-L-asparaginase for the treatment of acute lymphoblastic leukemia by Ettinger, L J, Kurtzberg, J, Voûte, P A, Jürgens, H, Halpern, S L

“…L-asparaginase has been a mainstay of therapy along with vincristine and prednisone in the treatment of acute lymphoblastic leukemia (ALL) in children for…”
Get more information

High dose chemotherapy with autologous bone marrow rescue for children with diffuse pontine brain stem tumors by DUNKEL, I. J, GARVIN, J. H, GOLDMAN, S, ETTINGER, L. J, KAPLAN, A. M, CAIRO, M, HAO LI, BOYETT, J. M, FINLAY, L

“…Purpose. Diffuse pontine tumors are highly lethal, and there are few long-term survivors with the standard treatment of external beam irradiation. We…”
Get full text

Asparaginases: where do we go from here? by Ettinger, L J

Get full text

Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial by Gaynon, P S, Ettinger, L J, Baum, E S, Siegel, S E, Krailo, M D, Hammond, G D

“…Between October 1985 and March 1988, Children's Cancer Study Group institutions entered 95 patients with recurrent brain tumors into a Phase II trial of…”
Get more information

Radiologic placement of a low profile implantable venous access port in a pediatric population by NOSHER, John L, BODNER, Leonard J, ETTINGER, Lawrence J, SIEGEL, Randall L, GRIBBIN, Christopher, ASCH, Julie, DRACHTMAN, Richard A

“…To evaluate the feasibility and complications of placement of a low-profile venous access port in the chest in children requiring long-term venous access. A…”
Get full text

A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer Group by Ettinger, L J, Gaynon, P S, Krailo, M D, Ru, N, Baum, E S, Siegel, S E, Hammond, G D

“…Carboplatin is an analogue of cisplatin with less nonhematologic toxicity than the parent compound. It has been demonstrated previously to have activity…”
Get more information

Phase I and pharmacokinetic evaluation of thiotepa in the cerebrospinal fluid and plasma of pediatric patients: evidence for dose-dependent plasma clearance of thiotepa by HEIDEMAN, R. L, COLE, D. E, POPLACK, D. G, BALIS, F, SATO, J, REAMAN, G. H, PACKER, R. J, SINGHER, L. J, ETTINGER, L. J, GILLESPIE, A, SAM, J

“…A Phase I trial of thiotepa (TT) administered as an i.v. bolus was performed in 19 children with refractory malignancies. The starting dose was 25 mg/m2 with…”
Get full text

Acute lymphoblastic leukaemia: a guide to asparaginase and pegaspargase therapy by Ettinger, L J, Ettinger, A G, Avramis, V I, Gaynon, P S

“…The cure rate for children with acute lymphoblastic leukaemia (ALL) has increased to approximately 70%, in part related to the use of the protein synthesis…”
Get full text

A phase I study of carboplatin in children with acute leukemia in bone marrow relapse. A report from the Childrens Cancer Group by Ettinger, L J, Krailo, M D, Gaynon, P S, Hammond, G D

“…Carboplatin is an analogue of cisplatin with less nonhematologic toxicity and a similar spectrum of antineoplastic activity as the parent compound. Although…”
Get more information

Long-term survival in an adolescent with widely metastatic Renal cell carcinoma with rhabdoid features by ETTINGER, L. J, GOODELL, L. A, JAVIDIAN, P, HSIEH, Y, AMENTA, P

“…Renal cell carcinoma is rarely seen in children and adolescents. Patients with widespread disease at diagnosis have a particularly poor survival rate…”
Get full text

Pharmacokinetics of intravenous recombinant human granulocyte colony‐stimulating factor (rhG‐CSF) in children receiving myelosuppressive cancer chemotherapy: Clearance increases in relation to absolute neutrophil count with repeated dosing by Sturgill, Marc G., Huhn, Richard D., Drachtman, Richard A., Ettinger, Alice G., Ettinger, Lawrence J.

“…Limited evidence suggests increased efficacy of rhG‐CSF by subcutaneous (SQ) compared with intravenous (IV) administration. To examine the possibility that…”
Get full text